Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919153 | Radiotherapy and Oncology | 2011 | 5 Pages |
Abstract
SBRT for OLTs is tolerable. The LCR for OLTs from origins other than colorectal cancer is excellent. However, LCR for colorectal OLTs is worse than that from other origins. Therefore dose escalation should be considered to achieve good local control for colorectal OLTs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Atsuya Takeda, Etsuo Kunieda, Toshio Ohashi, Yousuke Aoki, Naoyoshi Koike, Toshiaki Takeda,